These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10831035)

  • 1. Olanzapine treatment of methamphetamine psychosis.
    Misra LK; Kofoed L; Oesterheld JR; Richards GA
    J Clin Psychopharmacol; 2000 Jun; 20(3):393-4. PubMed ID: 10831035
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Friedman J
    Neurology; 1998 Apr; 50(4):1195-6. PubMed ID: 9566437
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine for l-dopa-induced psychosis in PD.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 2000 Apr; 54(7):1538. PubMed ID: 10751276
    [No Abstract]   [Full Text] [Related]  

  • 4. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
    Yamamoto N; Oda T; Inada T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):691-4. PubMed ID: 18081635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent psychosis after a single ingestion of 'ecstasy'.
    Van Kampen J; Katz M
    Psychosomatics; 2001; 42(6):525-7. PubMed ID: 11815690
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine: a proarrhythmic drug?
    Gupta N; Malhotra P
    Can J Psychiatry; 2002 Sep; 47(7):683-4. PubMed ID: 12355682
    [No Abstract]   [Full Text] [Related]  

  • 7. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.
    Breier A; Sutton VK; Feldman PD; Kadam DL; Ferchland I; Wright P; Friedman JH
    Biol Psychiatry; 2002 Sep; 52(5):438-45. PubMed ID: 12242060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone treatment of amphetamine psychosis.
    Jha A; Fourie H
    Br J Psychiatry; 1999 Apr; 174():366. PubMed ID: 10533557
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Gheuens J; Grebb JA
    J Clin Psychopharmacol; 1998 Apr; 18(2):176-9. PubMed ID: 9555606
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Schooler NR
    J Clin Psychopharmacol; 1998 Apr; 18(2):174-6. PubMed ID: 9555605
    [No Abstract]   [Full Text] [Related]  

  • 13. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluations of olanzapine and risperidone.
    Shaw JW
    Am J Health Syst Pharm; 2002 Jul; 59(14):1366-75. PubMed ID: 12132564
    [No Abstract]   [Full Text] [Related]  

  • 15. Return of menstruation after switching from risperidone to olanzapine.
    Gazzola LR; Opler LA
    J Clin Psychopharmacol; 1998 Dec; 18(6):486-7. PubMed ID: 9864085
    [No Abstract]   [Full Text] [Related]  

  • 16. Are the atypical antipsychotic drugs antidepressants?
    Parker G; Malhi G
    J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine and negative symptoms.
    Rosen EH
    J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost evaluation of risperidone compared with olanzapine.
    Byerly MJ; Weber M; Brooks D; Casey SB; Elliot S; Hawkins J
    Psychiatr Serv; 2003 May; 54(5):742-4. PubMed ID: 12719509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.